CYTH insider transaction filings
Cyclo Therapeutics, Inc. — 43 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-03-03. Screen CYTH transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CYTH between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — Cyclo Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-03-03 | 4 | STRATTAN CE RICK — Director | Grant/award (A): 30,169 @ $0 | EDGAR |
| 2025-03-03 | 4 | CONKLING WILLIAM — Director | Grant/award (A): 27,654 @ $0 | EDGAR |
| 2025-03-03 | 4 | Toig Randall M. — Director | Grant/award (A): 33,311 @ $0 | EDGAR |
| 2025-03-03 | 4 | Cross Shawn — Director | Grant/award (A): 28,597 @ $0 | EDGAR |
| 2025-03-03 | 4 | Wong Vivien — Director | Grant/award (A): 25,140 @ $0 | EDGAR |
| 2025-03-03 | 4 | Ostronic Francis Patrick — Director | Grant/award (A): 70,329 @ $0 | EDGAR |
| 2025-03-03 | 4 | Sieger Markus — Director | Grant/award (A): 58,138 @ $0 | EDGAR |
| 2025-02-28 | 4 | SHANAHAN WILLIAM S — Director | Grant/award (A): 25,140 @ $0 | EDGAR |
| 2025-01-13 | 4 | Rafael Holdings, Inc. — 10% owner | Conversion (C): 3,968,254 @ $0.63 | EDGAR |
| 2024-11-18 | 4 | STRATTAN CE RICK — Director | Grant/award (A): 63,608 @ $0 | EDGAR |
| 2024-11-18 | 4 | CONKLING WILLIAM — Director | Grant/award (A): 16,660 @ $0 | EDGAR |
| 2024-11-18 | 4 | Toig Randall M. — Director | Grant/award (A): 20,067 @ $0 | EDGAR |
| 2024-11-18 | 4 | Cross Shawn — Director | Grant/award (A): 17,228 @ $0 | EDGAR |
| 2024-11-18 | 4 | Wong Vivien — Director | Grant/award (A): 15,145 @ $0 | EDGAR |
| 2024-11-18 | 4 | Sieger Markus — Director | Grant/award (A): 35,022 @ $0 | EDGAR |
| 2024-11-18 | 4 | SHANAHAN WILLIAM S — Director | Grant/award (A): 15,145 @ $0 | EDGAR |
| 2024-08-20 | 4 | STRATTAN CE RICK — Director | Grant/award (A): 9,524 @ $0 | EDGAR |
| 2024-08-20 | 4 | CONKLING WILLIAM — Director | Grant/award (A): 8,731 @ $0 | EDGAR |
| 2024-08-20 | 4 | Toig Randall M. — Director | Grant/award (A): 10,516 @ $0 | EDGAR |
| 2024-08-20 | 4 | Cross Shawn — Director | Grant/award (A): 9,028 @ $0 | EDGAR |
| 2024-08-20 | 4 | Wong Vivien — Director | Grant/award (A): 7,937 @ $0 | EDGAR |
| 2024-08-20 | 4 | Sieger Markus — Director | Grant/award (A): 18,354 @ $0 | EDGAR |
| 2024-08-20 | 4 | SHANAHAN WILLIAM S — Director | Grant/award (A): 7,937 @ $0 | EDGAR |
| 2024-06-05 | 4 | STRATTAN CE RICK — Director | Grant/award (A): 9,375 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | CONKLING WILLIAM — Director | Grant/award (A): 8,594 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Lisjak Michael Eric — Chief Regulatory Officer | Grant/award (A): 110,732 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Fine Joshua M — Chief Financial Officer | Grant/award (A): 110,732 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Toig Randall M. — Director | Grant/award (A): 10,352 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Cross Shawn — Director | Grant/award (A): 8,887 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Wong Vivien — Director | Grant/award (A): 7,813 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Ostronic Francis Patrick — Director | Grant/award (A): 10,743 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | TATE JEFFREY — Chief Operating Officer, Director | Grant/award (A): 110,732 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Sieger Markus — Director | Grant/award (A): 18,067 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | SHANAHAN WILLIAM S — Director | Grant/award (A): 7,813 @ $0 · Grant/award (A): 15,562 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | FINE N SCOTT — Chief Executive Officer, Director | Grant/award (A): 266,354 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | STRATTAN CE RICK — Director | Grant/award (A): 6,963 @ $0 | EDGAR |
| 2024-02-15 | 4 | CONKLING WILLIAM — Director | Grant/award (A): 6,330 @ $0 | EDGAR |
| 2024-02-15 | 4 | Toig Randall M. — Director | Grant/award (A): 7,516 @ $0 | EDGAR |
| 2024-02-15 | 4 | Wong Vivien — Director | Grant/award (A): 6,330 @ $0 | EDGAR |
| 2024-02-15 | 4 | Ostronic Francis Patrick — Director | Grant/award (A): 8,703 @ $0 | EDGAR |
| 2024-02-15 | 4 | Sieger Markus — Director | Grant/award (A): 14,004 @ $0 | EDGAR |
| 2024-02-15 | 4 | SHANAHAN WILLIAM S — Director | Grant/award (A): 8,466 @ $0 | EDGAR |
| 2023-12-28 | 4 | Cross Shawn — Director | Grant/award (A): 72,606 @ $0 · Grant/award (A): 88,910 (derivative) @ $0 | EDGAR |
Recent 8-K events — Cyclo Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-03-26 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-03-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-02-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-01-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2025-01-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-12-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-11-08 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-10-09 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CYTH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →